Expression of FIBCD1 by intestinal epithelial cells alleviates inflammation-driven tumorigenesis in a mouse model of colorectal cancer
BackgroundColorectal cancer (CRC) ranks as the third most prevalent cancer globally, highlighting the pressing need to address its development. Inflammation plays a crucial role in augmenting the risk of CRC and actively contributes to all stages of tumorigenesis. Consequently, targeting early infla...
Main Authors: | Vahid Khaze Shahgoli, Magdalena Dubik, Bartosz Pilecki, Sofie Skallerup, Sandra Gaedt Schmidt, Sönke Detlefsen, Grith L. Sorensen, Uffe Holmskov, Behzad Baradaran, Jesper B. Moeller |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1280891/full |
Similar Items
-
FIBCD1 Binds Aspergillus fumigatus and Regulates Lung Epithelial Response to Cell Wall Components
by: Christine Schoeler Jepsen, et al.
Published: (2018-09-01) -
FIBCD1 is an endocytic GAG receptor associated with a novel neurodevelopmental disorder
by: Christopher W Fell, et al.
Published: (2022-08-01) -
Bifidobacterium longum suppresses colorectal cancer through the modulation of intestinal microbes and immune function
by: Fangjian Shang, et al.
Published: (2024-03-01) -
Theabrownin Alleviates Colorectal Tumorigenesis in Murine AOM/DSS Model via PI3K/Akt/mTOR Pathway Suppression and Gut Microbiota Modulation
by: Hoi Kit Matthew Leung, et al.
Published: (2022-08-01) -
Integrated analysis of the gut microbiome and metabolome in a mouse model of inflammation-induced colorectal tumors
by: Yuntian Hong, et al.
Published: (2023-01-01)